HRP970260A2 - 2,4-diaminopyrimidine derivatives - Google Patents

2,4-diaminopyrimidine derivatives

Info

Publication number
HRP970260A2
HRP970260A2 HR96107739.3A HRP970260A HRP970260A2 HR P970260 A2 HRP970260 A2 HR P970260A2 HR P970260 A HRP970260 A HR P970260A HR P970260 A2 HRP970260 A2 HR P970260A2
Authority
HR
Croatia
Prior art keywords
diaminopyrimidine derivatives
diaminopyrimidine
derivatives
Prior art date
Application number
HR96107739.3A
Other languages
English (en)
Inventor
Philippe Guerry
Henri Stalder
Pierre-Charles Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HRP970260A2 publication Critical patent/HRP970260A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
HR96107739.3A 1996-05-15 1997-05-15 2,4-diaminopyrimidine derivatives HRP970260A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96107739 1996-05-15

Publications (1)

Publication Number Publication Date
HRP970260A2 true HRP970260A2 (en) 1998-04-30

Family

ID=8222784

Family Applications (1)

Application Number Title Priority Date Filing Date
HR96107739.3A HRP970260A2 (en) 1996-05-15 1997-05-15 2,4-diaminopyrimidine derivatives

Country Status (29)

Country Link
US (1) US5866583A (xx)
EP (1) EP0901488B1 (xx)
JP (1) JP3098259B2 (xx)
KR (1) KR100295509B1 (xx)
CN (1) CN1098260C (xx)
AR (1) AR007088A1 (xx)
AT (1) ATE227282T1 (xx)
AU (1) AU726416B2 (xx)
BR (1) BR9709251A (xx)
CA (1) CA2254117C (xx)
CO (1) CO4840509A1 (xx)
CY (1) CY2425B1 (xx)
CZ (1) CZ364698A3 (xx)
DE (1) DE69716901T2 (xx)
DK (1) DK0901488T3 (xx)
ES (1) ES2184089T3 (xx)
HR (1) HRP970260A2 (xx)
IL (1) IL126702A0 (xx)
MA (1) MA24182A1 (xx)
NO (1) NO985335L (xx)
NZ (1) NZ332481A (xx)
PE (1) PE78898A1 (xx)
PL (1) PL330277A1 (xx)
PT (1) PT901488E (xx)
TR (1) TR199802331T2 (xx)
TW (1) TW438796B (xx)
WO (1) WO1997043277A1 (xx)
YU (1) YU51498A (xx)
ZA (1) ZA973984B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0966464B1 (en) * 1997-03-03 2003-05-28 Basilea Pharmaceutica AG Substituted 2,4-diaminopyrimidines
TR199902140T2 (en) * 1997-03-03 2000-04-21 F. Hoffmann-La Roche Ag S�bstit�e edilmi� 2,4-diaminopirimidinler.
US6277860B1 (en) * 1999-10-29 2001-08-21 Pfizer Inc Furopyridine antibacterials
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
EP1633351A1 (en) * 2003-06-13 2006-03-15 Arena Pharmaceuticals, Inc. 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
CN1832741A (zh) * 2003-08-07 2006-09-13 默克公司 作为11-β-羟甾类脱氢酶-1抑制剂的吡唑甲酰胺类
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
DE102005062987A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
WO2009019149A1 (en) * 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
EP2386546B1 (en) * 2008-11-21 2015-08-19 RaQualia Pharma Inc Novel pyrazole-3-carboxamide derivate having 5-ht2b receptor antagonist activity
CN102361863B (zh) * 2009-01-21 2014-12-03 巴斯利尔药物股份公司 新的二环抗生素
MX2012006723A (es) * 2009-12-15 2012-06-28 Bayer Cropscience Ag Procedimiento para la preparacion de derivados de acido 1-alquil-/1-aril-5-pirazolcarboxilico.
UA108926C2 (xx) 2011-04-05 2015-06-25 Пфайзер Лімітед ПІРОЛО$2,3-d]ПІРИМІДИНОВІ ІНГІБІТОРИ ТРОПОМІОЗИНЗАЛЕЖНОЇ КІНАЗИ
DE102013208484B4 (de) 2013-05-08 2018-04-26 Wirtgen Gmbh Vorrichtung zum Bearbeiten von Straßen- oder Bodenoberflächen, sowie Verfahren zum Lenken einer Straßenfräsmaschine
AR117169A1 (es) * 2018-11-28 2021-07-14 Bayer Ag (tio)amidas de piridazina como compuestos fungicidas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
US4013644A (en) * 1976-03-15 1977-03-22 G. D. Searle & Co. [8 α(E), 13aβ]-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-8-(2-phenylethenyl)-6H-dibenzo[a,g]quinolizines and intermediates thereto
NO811630L (no) * 1980-05-29 1981-11-30 Bayer Ag Imidazoazolalkensyreamider, nye mellomprodukter for deres fremstilling, deres fremstilling og deres anvendelse som legemiddel
US4594199A (en) * 1983-09-19 1986-06-10 E. R. Squibb & Sons, Inc. Method for making phosphinic acid intermediates
JPH07509215A (ja) * 1990-11-14 1995-10-12 カイロン コーポレイション ジヒドロ葉酸還元酵素の特異的阻害およびそのための化合物
US5763450A (en) * 1994-11-24 1998-06-09 Hoffmann-La Roche Inc. Substituted benzyl pyrimidines
WO1996040640A1 (en) * 1995-06-07 1996-12-19 Pfizer Inc. BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
WO1997020839A1 (en) * 1995-12-04 1997-06-12 F. Hoffmann-La Roche Ag Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial

Also Published As

Publication number Publication date
WO1997043277A1 (en) 1997-11-20
CY2425B1 (en) 2004-11-12
JPH11511749A (ja) 1999-10-12
EP0901488B1 (en) 2002-11-06
ZA973984B (en) 1997-11-17
IL126702A0 (en) 1999-08-17
CO4840509A1 (es) 1999-09-27
EP0901488A1 (en) 1999-03-17
CN1098260C (zh) 2003-01-08
PT901488E (pt) 2003-03-31
CA2254117A1 (en) 1997-11-20
TW438796B (en) 2001-06-07
KR100295509B1 (ko) 2001-09-17
DK0901488T3 (da) 2003-03-03
MA24182A1 (fr) 1997-12-31
JP3098259B2 (ja) 2000-10-16
BR9709251A (pt) 1999-08-10
DE69716901T2 (de) 2003-09-18
NO985335L (no) 1999-01-15
NZ332481A (en) 2000-04-28
ES2184089T3 (es) 2003-04-01
AR007088A1 (es) 1999-10-13
CZ364698A3 (cs) 1999-02-17
CN1218465A (zh) 1999-06-02
PL330277A1 (en) 1999-05-10
US5866583A (en) 1999-02-02
KR20000011053A (ko) 2000-02-25
TR199802331T2 (xx) 1999-04-21
AU2894297A (en) 1997-12-05
NO985335D0 (no) 1998-11-16
CA2254117C (en) 2003-03-11
DE69716901D1 (de) 2002-12-12
AU726416B2 (en) 2000-11-09
YU51498A (en) 1999-11-22
PE78898A1 (es) 1998-11-13
ATE227282T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
HUP9903965A3 (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
IL141908A (en) 1,4-benzodiazepine derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA986358B (en) Dolastatin 15 derivatives.
AU1416195A (en) Substituted 1,2,3,4-tetrahydro-5-nitro pyrimidines
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
SG71173A1 (en) 1,3,8,-triaza-spiro[4,5]decan-4-on derivatives
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
IL126702A0 (en) 2,4-Diaminopyrimidine derivatives
AP9500731A0 (en) 1,5 benzodiazepine derivatives
GB2311779B (en) 2,3 benzodiazepine derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
ZA981529B (en) Substituted 2,4-diaminopyrimidine
IL132162A (en) 2,3-epoxypropionamide derivatives
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives
ZA977881B (en) N-benzylazolium derivatives.
ZA972692B (en) Pyrrolopyrrolone derivatives.
EP0679651A3 (en) Thiadiazinone derivatives.
ZA953056B (en) 1,5 benzodiazepine derivatives
GB9406037D0 (en) 1,5 Benzodiazepine derivatives
ZA965384B (en) 4-Amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected